Response of malignant scalp dermatofibrosarcoma to presurgical targeted growth factor inhibition: Case report

Journal of Neurosurgery

Volumn 112, Issue 5, 2010, Pages 965-977

  Mattox, Austin K ^a   Mehta, Ankit I ^a   Grossi, Peter M ^a   Cumm Ings, Thoma S J ^a   Adamson, D Cory ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Gleevec; Imatinib; Scalp dermatofibrosarcoma

Indexed keywords

BEVACIZUMAB; DASATINIB; IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SUNITINIB;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DERMATOFIBROSARCOMA PROTUBERANS; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; FATIGUE; HISTIOCYTOMA; HUMAN; HUMAN TISSUE; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PRIORITY JOURNAL; SKIN BIOPSY;

ANTINEOPLASTIC AGENTS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 22; COLLAGEN TYPE I; DERMATOFIBROSARCOMA; EPIDERMAL GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SCALP; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 77952063701     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.7.JNS09522     Document Type: Article

References (67)

1. Ballo MT, Zagars GK, Pisters P, Pollack A: The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys 40:823-827, 1998 (Pubitemid 28150799)
2. Barnes L, Coleman JA Jr, Johnson JT: Dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol 110: 398-404, 1984
3. Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, et al: Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 88:2711-2720, 2000
4. Bridge JA, Neff JR, Sandberg AA: Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49:199-202, 1990
5. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, et al: Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacol Exp Ther 295:139-145, 2000
6. Buchdunger E, O'Reilly T, Wood J: Pharmacology of imatinib (STI571). Eur J Cancer 38 (5 Suppl):S28-S36, 2002
7. Burkhardt BR, Soule EH, Winkelmann RK, Ivins JC: Dermatofibrosarcoma protuberans. Study of fifty-six cases. Am J Surg 111:638-644, 1966
8. Cakir B, Misirlioglu A, Gideroglu K, Akoz T: Giant fibrosarcoma arising in dermatofibrosarcoma protuberans on the scalp during pregnancy. Dermatol Surg 29:297-299, 2003 (Pubitemid 36343532)
9. Calikoglu E, Augsburger E, Chavaz P, Saurat JH, Kaya G: CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. J Cutan Pathol 30:185-189, 2003 (Pubitemid 36428427)
10. Chang CK, Jacobs IA, Salti GI: Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 30:341-345, 2004
11. Connelly JH, Evans HL: Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 16:921-925, 1992
12. Costa MJ, McGlothlen L, Pierce M, Munn R, Vogt PJ: Angiomatoid features in fibrohistiocytic sarcomas. Immunohistochemical, ultrastructural, and clinical distinction from vascular neoplastms. Arch Pathol Lab Med 1119:1065-1171, 1995 (Pubitemid 26063815)
13. Das L, Grover SB, Chand K, Dawson L: Intracranial extension of a dermatofibrosarcoma protuberans of the scalp: a case report with brief review of the literature. Surg Neurol 54: 452-454, 2000 (Pubitemid 32184661)
14. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037, 2001 (Pubitemid 32267972)
15. DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK: Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer 100:1008-1016, 2004 (Pubitemid 38222862)
16. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106-120, 1980 (Pubitemid 11217753)
17. Enzinger F, Weiss SW: Soft Tissue Tumors, ed 2. St. Louis: Mosby, 1995
18. Filipowicz EA, Ventura KC, Pou AM, Logrono R: FNAC in the diagnosis of recurrent dermatofibrosarcoma protuberans of the forehead. A case report. Acta Cytol 43:1177-1180, 1999
19. Gloster HM, Jr: Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35:355-374, 1996
20. Goldblum JR, Reith JD, Weiss SW: Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol 24:1125-1130, 2000
21. Hirabayashi S, Kajikawa A, Kanazawa K, Mimoto K: Dermatofibrosarcoma protuberans with regional lymph node metastasis: a case report. Head Neck 11:562-564, 1989 (Pubitemid 19280995)
22. Huether MJ, Zitelli JA, Brodland DG: Mohs micrographic surgery for the treatment of spindle cell tumors of the skin. J Am Acad Dermatol 44:656-659, 2001 (Pubitemid 32249525)
23. Khachemoune A, Barkoe D, Braun M III, Davison SP: Dermatofibrosarcoma of the forehead and scalp with involvement of the outer calvarial plate: multistaged repair with the use of skin expanders. Dermatol Surg 31:115-119, 2005 (Pubitemid 40094076)
24. King M, Ocheltree I: Dermatofibrosarcoma protuberans treatment and reconstruction: a case study. Plast Surg Nurs 16: 77-82, 1996
25. Koshima I, Inagawa K, Jitsuiki Y, Tsuda K, Moriguchi T, Watanabe A: Scarpa's adipofascial flap for repair of wide scalp defects. Ann Plast Surg 36:88-92, 1996 (Pubitemid 26042258)
26. Kovarik CL, Hsu MY, Cockerell CJ: Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm. J Cutan Pathol 31:492-496, 2004
27. Labropoulos SV, Fletcher JA, Oliveira AM, Papadopoulos S, Razis ED: Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate. Anticancer Drugs 16:461-466, 2005 (Pubitemid 40434613)
28. Lindner NJ, Scarborough MT, Powell GJ, Spanier S, Enneking WF: Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol 25:392-397, 1999 (Pubitemid 29364226)
29. Loss L, Zeitouni NC: Management of scalp dermatofibrosarcoma protuberans. Dermatol Surg 31:1428-1433, 2005
30. Madani S, Huilgol SC, Carruthers A: Unplanned incomplete Mohs micrographic surgery. J Am Acad Dermatol 42:814-819, 2000 (Pubitemid 30252888)
31. Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR: Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 100:623-626, 2002 (Pubitemid 34832970)
32. Mandahl N, Heim S, Willen H, Rydholm A, Mitelman F: Supernumerary ring chromosome as the sole cytogenetic abnormality in a dermatofibrosarcoma protuberans. Cancer Genet Cytogenet 49:273-275, 1990 (Pubitemid 20372145)
33. Marks LB, Suit HD, Rosenberg AE, Wood WC: Dermatofibrosarcoma protuberans treated with radiation therapy. Int J Radiat Oncol Biol Phys 17:379-384, 1989
34. McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, et al: Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 23:866-873, 2005 (Pubitemid 46224187)
35. McLoughlin PM, Girach M, Wood GA: Dermatofibrosarcoma protuberans of the scalp. Br J Oral Maxillofac Surg 30:401-403, 1992
36. Mehrany K, Swanson NA, Heinrich MC, Weenig RH, Lee KK, White CR Jr, et al: Dermatofibrosarcoma protuberans: a partial response to imatinib therapy. Dermatol Surg 32:456-459, 2006
37. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD: Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol 22:576-587, 1998 (Pubitemid 28213745)
38. Minoletti F, Miozzo M, Pedeutour F, Sard L, Pilotti S, Azzarelli A, et al: Involvement of chromosomes 17 and 22 in dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 13: 62-65, 1995
39. Mizutani K, Tamada Y, Hara K, Tsuzuki T, Saeki H, Tamaki K, et al: Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans. Br J Dermatol 151:235-237, 2004 (Pubitemid 39061309)
40. Naeem R, Lux ML, Huang SF, Naber SP, Corson JM, Fletcher JA: Ring chromosomes in dermatofibrosarcoma protuberans are composed of interspersed sequences from chromosomes 17 and 22. Am J Pathol 147:1553-1558, 1995
41. Nouri K, Lodha R, Jimenez G, Robins P: Mohs micrographic surgery for dermatofibrosarcoma protuberans: University of Miami and NYU experience. Dermatol Surg 28:1060-1064, 2002 (Pubitemid 35424808)
42. O'Connell JX, Trotter MJ: Fibrosarcomatous dermatofibrosarcoma protuberans with myofibroblastic differentiation: a histologically distinctive variant. Mod Pathol 9:273-278, 1996
43. Pedeutour F, Coindre JM, Nicolo G, Bouchot C, Ayraud N, Carel CT: Ring chromosomes in dermatofibrosarcoma protuberans contain chromosome 17 sequences: fluorescence in situ hybridization. Cancer Genet Cytogenet 67:149, 1993 (Pubitemid 23198847)
44. Price VE, Fletcher JA, Zielenska M, Cole W, Viero S, Manson DE, et al: Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans. Pediatr Blood Cancer 44:511-515, 2005 (Pubitemid 40614501)
45. Rich JD, Zbylski JR, LaRossa DD: Dermatofibrosarcoma protuberans of the head and neck. Am Surg 46:208-215, 1980
46. Robinson JK: Dermatofibrosarcoma protuberans resected by Mohs' surgery (chemosurgery). A 5-year prospective study. J Am Acad Dermatol 12:1093-1098, 1985
47. Rockley PF, Robinson JK, Magid M, Goldblatt D: Dermatofibrosarcoma protuberans of the scalp: a series of cases. J Am Acad Dermatol 21:278-283, 1989 (Pubitemid 19195891)
48. Roy L, Guilhot J, Krahnke T, Guerci-Bresler A, Druker BJ, Larson RA, et al: Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials. Blood 108:1478-1484, 2006 (Pubitemid 44316111)
49. Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, et al: Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 20:3586-3591, 2002 (Pubitemid 34983217)
50. Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E: Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol 18:241-248, 1992
51. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, et al: Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15:95-98, 1997 (Pubitemid 27014958)
52. Sinha VD, Dharker SR, Kalra GS: Dermatofibrosarcoma protuberans of the scalp: a case report. Neurol India 49:81-83, 2001 (Pubitemid 32385281)
53. Sirvent N, Maire G, Pedeutour F: Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 37:1-19, 2003 (Pubitemid 36417917)
54. Sjoblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, et al: Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res 61:5778-5783, 2001 (Pubitemid 32769094)
55. Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB: Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer 101:28-38, 2004
56. Stenman G, Anderson H, Meis-Kindblom JM, Roijer E, Kindblom LG: FISH analysis of supernumerary ring chromosome in dermatofibrosarcoma protuberans. Int J Oncol 6:81-86, 1995 (Pubitemid 24382849)
57. Suit H, Spiro I, Mankin HJ, Efird J, Rosenberg AE: Radiation in management of patients with dermatofibrosarcoma protuberans. J Clin Oncol 14:2365-2369, 1996 (Pubitemid 26264889)
58. Sun LM, Wang CJ, Huang CC, Leung SW, Chen HC, Fang FM, et al: Dermatofibrosarcoma protuberans: treatment results of 35 cases. Radiother Oncol 57:175-181, 2000
59. Taniguchi Y, Tamaki T, Yoshida M, Uematsu Y: Reconstruction of a scalp and skull deficit with free latissimus dorsi myocutaneous flap following dermatofibrosarcoma protuberans. J Orthop Surg (Hong Kong) 10:206-209, 2002 (Pubitemid 36193927)
60. Taylor HB, Helwig EB: Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 15:717-725, 1962
61. Taylor R: Sarcomatous tumors resembling in some respects keloids. Arch Dermatol 8:384-387, 1890
62. Torreggiani WC, Al-Ismail K, Munk PL, Nicolaou S, O'Connell JX, Knowling MA: Dermatofibrosarcoma protuberans: MR imaging features. AJR Am J Roentgenol 178:989-993, 2002
63. Uematsu Y, Fukai J, Tamura M, Owai Y, Obayashi S, Nakai K, et al: Distant metastasis of dermatofibrosarcoma protuberans of the scalp-case report. Neurol Med Chir (Tokyo) 43:493-496, 2003 (Pubitemid 37295591)
64. van Oosterom AT, Judson I, Verweij J, Stroobants S, Donato di Paola E, Dimitrijevic S, et al: Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358:1421-1423, 2001 (Pubitemid 33055745)
65. Wacker J, Khan-Durani B, Hartschuh W: Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol 11: 438-444, 2004 (Pubitemid 40486756)
66. Weiss SW, Nickoloff BJ: CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 17:1039-1045, 1993
67. Wright TI, Petersen JE: Treatment of recurrent dermatofibrosarcoma protuberans with imatinib mesylate, followed by Mohs micrographic surgery. Dermatol Surg 33:741-744, 2007